Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative sedation after cardiac surgery
ACTRN12609000199213Phase 4Withdrawn
- Sponsor
- The University of Auckland
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in postoperative recovery (2 arms), sponsored by The University of Auckland. Primary endpoint: Concentration-effect relationship for dexmedetomidine and sedation, blood pressure, and heart rate. Planned start May 2009; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
postoperative recovery
Beyond the preview
Go deeper on ACTRN12609000199213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000199213.